Irinotecan in Treating Patients With Refractory Solid Tumors and Liver Dysfunction - No Study Results Posted

Home Search Study Topics Glossary

Irinotecan in Treating Patients With Refractory Solid Tumors and Liver Dysfunction

This study has been completed.

Study NCT00037804 Information provided by Pfizer

First Received: May 21, 2002 Last Updated: August 13, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	No date given